CH631740A5 - Process for the preparation of maytansinol and its derivatives - Google Patents

Process for the preparation of maytansinol and its derivatives Download PDF

Info

Publication number
CH631740A5
CH631740A5 CH1260477A CH1260477A CH631740A5 CH 631740 A5 CH631740 A5 CH 631740A5 CH 1260477 A CH1260477 A CH 1260477A CH 1260477 A CH1260477 A CH 1260477A CH 631740 A5 CH631740 A5 CH 631740A5
Authority
CH
Switzerland
Prior art keywords
parts
volume
maytansinol
maytanacin
ethyl acetate
Prior art date
Application number
CH1260477A
Other languages
German (de)
English (en)
Inventor
Eiji Higashide
Mitsuko Asai
Seiichi Tanida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CH631740A5 publication Critical patent/CH631740A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH1260477A 1977-03-31 1977-10-14 Process for the preparation of maytansinol and its derivatives CH631740A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52037167A JPS6010718B2 (ja) 1977-03-31 1977-03-31 メイタンシノ−ル,メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法

Publications (1)

Publication Number Publication Date
CH631740A5 true CH631740A5 (en) 1982-08-31

Family

ID=12490032

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1260477A CH631740A5 (en) 1977-03-31 1977-10-14 Process for the preparation of maytansinol and its derivatives

Country Status (20)

Country Link
JP (1) JPS6010718B2 ( )
AT (1) AT362058B ( )
AU (1) AU507869B2 ( )
CA (1) CA1092999A ( )
CH (1) CH631740A5 ( )
CS (1) CS214881B2 ( )
DE (1) DE2746253C2 ( )
DK (1) DK143570C ( )
ES (1) ES463206A1 ( )
FR (1) FR2385798A1 ( )
GB (1) GB1554395A ( )
HU (1) HU177391B ( )
IE (1) IE45888B1 ( )
IT (1) IT1094003B ( )
NL (1) NL7711273A ( )
PL (1) PL108863B1 ( )
PT (1) PT67853B ( )
SE (1) SE7711543L ( )
SU (1) SU938746A3 ( )
YU (1) YU243777A ( )

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6016236B2 (ja) * 1977-11-18 1985-04-24 武田薬品工業株式会社 抗生物質c―15003 p―3の製造法
JPS6010720B2 (ja) * 1977-11-18 1985-03-19 武田薬品工業株式会社 抗生物質c―15003 p―4の製造法
JPS55162791A (en) * 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
EP0028683A1 (en) * 1979-09-21 1981-05-20 Takeda Chemical Industries, Ltd. Antibiotic C-15003 PHO and production thereof
US6573074B2 (en) * 2000-04-12 2003-06-03 Smithkline Beecham Plc Methods for ansamitocin production
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US7432088B2 (en) 2003-05-08 2008-10-07 Immunogen Inc. Methods for the production of ansamitocins
CN116239607B (zh) * 2023-01-04 2024-04-09 山东大学 一种美登素衍生物及其生物合成方法与应用

Also Published As

Publication number Publication date
IE45888L (en) 1978-09-30
ATA736377A (de) 1980-09-15
PL201539A1 (pl) 1978-09-25
JPS6010718B2 (ja) 1985-03-19
PT67853A (en) 1978-04-01
AU2907377A (en) 1979-03-29
AU507869B2 (en) 1980-02-28
SE7711543L (sv) 1978-10-01
SU938746A3 (ru) 1982-06-23
DK458977A (da) 1978-10-01
IT1094003B (it) 1985-07-26
YU243777A (en) 1982-06-30
CA1092999A (en) 1981-01-06
DK143570B (da) 1981-09-07
DE2746253A1 (de) 1978-10-05
GB1554395A (en) 1979-10-17
PL108863B1 (en) 1980-05-31
FR2385798A1 (fr) 1978-10-27
IE45888B1 (en) 1982-12-29
FR2385798B1 ( ) 1980-04-25
ES463206A1 (es) 1978-08-16
CS214881B2 (en) 1982-06-25
JPS53121998A (en) 1978-10-24
DE2746253C2 (de) 1986-08-21
PT67853B (en) 1980-05-05
NL7711273A (nl) 1978-10-03
IT7821819A0 (it) 1978-03-30
DK143570C (da) 1982-02-08
AT362058B (de) 1981-04-27
HU177391B (en) 1981-09-28

Similar Documents

Publication Publication Date Title
CH638194A5 (de) Esterastin, eine neue physiologisch wirksame substanz und deren herstellung.
DE2849696A1 (de) Verfahren zur herstellung des antibiotikums c-15003 p-3
DE2746253C2 (de) Verfahren zur Herstellung von Maytansinol und dessen Derivaten
DE3234203C2 ( )
DE3012565A1 (de) Antitumor-antibakterielle mittel
DE3012014C2 (de) Istamycine, Verfahren zu deren Herstellung sowie Verwendung derselben als antibakterielle Mittel
DE2839668C2 ( )
DE2746209C2 ( )
DE2833689C2 ( )
DE3003359C2 ( )
CH640269A5 (de) Verfahren zur herstellung des antibiotikums c-15003 p-4.
DE2921085C2 ( )
DE2725163C2 ( )
DE2456139C3 (de) Verfahren zur Herstellung des Antibiotikums 20.798 R.P
DE2817113A1 (de) Hydroxynovobiocinartige verbindungen und verfahren zu ihrer herstellung
CH637137A5 (en) Antibiotic and process for its preparation
DE2746252A1 (de) Antibiotikum c-15003 enthaltendes arzneimittel zur behandlung von tumore aufweisenden warmbluetern
DE2039990C2 (de) Neue Antibiotika B-5050 A bis F (Maridomycin I bis VI), Verfahren zu ihrer Herstellung und ihre pharmazeutische Zubereitung
DE2813416C2 (de) Neue Antibiotika C-14919 E-1 und E-2 und Verfahren zu ihrer Herstellung
DE1077380B (de) Herstellung des Antibiotikums Lemacidin
DE2610557A1 (de) Neues naphthacenderivat, seine herstellung und dieses enthaltende zusammensetzungen
DE2944143C2 (de) Antibiotikum SF-2052, Verfahren zu dessen Herstellung und das Antibiotikum SF-2052 enthaltende antibakterielle Mittel
EP0182208A2 (de) Urdamycine, Verfahren und Streptomyceten-Stamm zu ihrer Herstellung und ihre Verwendung
DE3706838A1 (de) Neue, physiologisch aktive substanz "aldostatin" und verfahren zu ihrer herstellung
AT220290B (de) Verfahren zur Herstellung eines neuen Antibiotikums

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD

PL Patent ceased